Patents by Inventor Ching-Hu Chung

Ching-Hu Chung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aurantiamide dipeptide derivatives for treatment or prevention of angiogenesis-related diseases
    Patent number: 9872882
    Abstract: The invention relates to a use of an aurantiamide dipepetide derivative in the treatment or prevention of angiogenesis-related diseases. Accordingly, aurantiamide dipeptide derivatives can be used as angiogenesis inhibitor, whereby preventing or treating invasive and metastatic cancer and ocular neovascularization (particularly macular degeneration such as pathological neovascularization of age-related macular degeneration (AMD)).
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: January 23, 2018
    Assignees: MACKAY MEDICAL COLLEGE, MACKAY MEDICAL FOUNDATION THE PRESBYTERIAN CHURCH IN TAIWAN MACKAY MEMORIAL HOSPITAL, CHANG GUNG UNIVERSITY
    Inventors: Hung-I Yeh, Shih-Wei Wang, Ching-Hu Chung, Pei-Wen Hsieh
  • Peptide compounds for inhibitions of platelet aggregation
    Patent number: 9862747
    Abstract: The invention relates to a peptide compound and its pharmaceutical composition for inhibiting platelet aggregation and preventing/treating thrombogenic diseases. The invention develops pentapeptides and hexapeptides derived from snake venom C-type lectin-like proteins (CLPs) fragments, which can inhibit platelet aggregation and have antithrombotic activity without hemorrhagic tendency. Accordingly, they can be used as potential agents for the prevention and therapy of thrombogenic diseases.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: January 9, 2018
    Assignee: NATIONAL TAIWAN UNIVERSITY
    Inventors: Tur-Fu Huang, Chien-Hsin Chang, Ching-Hu Chung
  • PEPTIDE COMPOUNDS FOR INHIBITIONS OF PLATELET AGGREGATION
    Publication number: 20170218020
    Abstract: The invention relates to a peptide compound and its pharmaceutical composition for inhibiting platelet aggregation and preventing/treating thrombogenic diseases. The invention develops pentapeptides and hexapeptides derived from snake venom C-type lectin-like proteins (CLPs) fragments, which can inhibit platelet aggregation and have antithrombotic activity without hemorrhagic tendency. Accordingly, they can be used as potential agents for the prevention and therapy of thrombogenic diseases.
    Type: Application
    Filed: February 27, 2017
    Publication date: August 3, 2017
    Inventors: TUR-FU HUANG, CHIEN-HSIN CHANG, CHING-HU CHUNG
  • AURANTIAMIDE DIPEPTIDE DERIVATIVES FOR TREATMENT OR PREVENTION OF ANGIOGENESIS-RELATED DISEASES
    Publication number: 20170182114
    Abstract: The invention relates to a use of an aurantiamide dipepetide derivative in the treatment or prevention of angiogenesis-related diseases. Accordingly, aurantiamide dipeptide derivatives can be used as angiogenesis inhibitor, whereby preventing or treating invasive and metastatic cancer and ocular neovascularization (particularly macular degeneration such as pathological neovascularization of age-related macular degeneration (AMD)).
    Type: Application
    Filed: December 28, 2015
    Publication date: June 29, 2017
    Inventors: Hung-I YEH, Shih-Wei WANG, Ching-Hu CHUNG, Pei-Wen HSIEH
  • Peptide compounds for inhibition of platelet aggregation
    Patent number: 9617302
    Abstract: The invention relates to a peptide compound and its pharmaceutical composition for inhibiting platelet aggregation and preventing/treating thrombogenic diseases. The invention develops pentapeptides and hexapeptides derived from snake venom C-type lectin-like proteins (CLPs) fragments, which can inhibit platelet aggregation and have antithrombotic activity without hemorrhagic tendency. Accordingly, they can be used as potential agents for the prevention and therapy of thrombogenic diseases.
    Type: Grant
    Filed: June 14, 2012
    Date of Patent: April 11, 2017
    Assignee: NATIONAL TAIWAN UNIVERSITY
    Inventors: Tur-Fu Huang, Chien-Hsin Chang, Ching-Hu Chung
  • PEPTIDE COMPOUNDS FOR INHIBITION OF PLATELET AGGREGATION
    Publication number: 20140363423
    Abstract: The invention relates to a peptide compound and its pharmaceutical composition for inhibiting platelet aggregation and preventing/treating thrombogenic diseases. The invention develops pentapeptides and hexapeptides derived from snake venom C-type lectin-like proteins (CLPs) fragments, which can inhibit platelet aggregation and have antithrombotic activity without hemorrhagic tendency. Accordingly, they can be used as potential agents for the prevention and therapy of thrombogenic diseases.
    Type: Application
    Filed: June 14, 2012
    Publication date: December 11, 2014
    Inventors: Tur-Fu Huang, Chien-Hsin Chang, Ching-Hu Chung